Revance Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $285k | 32k | 8.79 |
| 2023-06-30 | $1.1M | 44k | 25.31 |
| 2023-03-31 | $4.2M | 132k | 32.21 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management